Associations of prenatal isoflavones exposure with maternal and child urinary kisspeptin levels and their interaction with bisphenols

Introduction Human evidence on associations between prenatal exposure to isoflavones (ISOs), naturally occurring phytoestrogens, and urinary kisspeptin levels remain limited, particularly regarding the interaction with synthetic estrogenic compounds, like bisphenol analogues (BPs). This study aimed to examine the associations of prenatal ISOs exposure with urinary kisspeptin levels in two critical life stages, pregnancy and pre-puberty in pregnant women and their children, respectively, and to explore the interaction between ISOs and BPs exposure. Methods We included 471 mother–child pairs from the Shanghai-Minhang Birth Cohort Study. Maternal ISOs exposure was assessed using urinary concentrations in samples collected at 12–16 gestational weeks, whereas maternal urinary kisspeptin levels were determined using urine samples collected at 32–36 gestational weeks. Children’s urine samples were collected at age 6 and analyzed for urinary kisspeptin levels. Associations between ISOs exposure and urinary kisspeptin levels were evaluated using multiple linear regression and Bayesian Kernel Machine Regression (BKMR), and interaction with BPs was assessed via interaction terms and stratified analyses. Results Higher prenatal exposure to ISOs, including daidzein (DAD), glycitein (GLY) and equol (EQU) were associated with increased maternal urinary kisspeptin levels. In children, higher ISOs exposure was mainly associated with patterns toward lower kisspeptin levels among girls. GLY showed relatively high posterior inclusion probabilities in BKMR. Exploratory analyses suggested interactions between prenatal GLY and BPF exposures in relation to maternal and child urinary kisspeptin levels. Discussion Our study provides the first epidemiologic evidence that prenatal ISOs exposure, particularly GLY, may be associated with maternal urinary kisspeptin levels, whereas evidence for inverse associations with children’s urinary kisspeptin levels was mainly observed among girls. The exploratory interaction with BPF highlights the potential importance of considering exposures across pregnancy, although this exploratory finding warrants further corroboration.

Authors

Institutions

Publication Details

Journal
Frontiers in Endocrinology
Published
2026-11-12
DOI
https://doi.org/10.3389/fendo.2026.1977571
Primary Topic
Phytoestrogen effects and research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Associations of prenatal isoflavones exposure with maternal and child urinary kisspeptin levels and their interaction with bisphenols

汪利强, Wei Yuan, Xiuxia Song, Maohua Miao et al.
Frontiers in Endocrinology
Phytoestrogen effects and research
article

Associations of prenatal isoflavones exposure with maternal and child urinary kisspeptin levels and their interaction with bisphenols

汪利强, Wei Yuan, Xiuxia Song, Maohua Miao, Yingchen Zhou, Hongchao Lian, Tianyu Sun, Yao Chen, Longmei Jin, Ziliang Wang, Gengsheng He
article en

Abstract

Introduction Human evidence on associations between prenatal exposure to isoflavones (ISOs), naturally occurring phytoestrogens, and urinary kisspeptin levels remain limited, particularly regarding the interaction with synthetic estrogenic compounds, like bisphenol analogues (BPs). This study aimed to examine the associations of prenatal ISOs exposure with urinary kisspeptin levels in two critical life stages, pregnancy and pre-puberty in pregnant women and their children, respectively, and to explore the interaction between ISOs and BPs exposure. Methods We included 471 mother–child pairs from the Shanghai-Minhang Birth Cohort Study. Maternal ISOs exposure was assessed using urinary concentrations in samples collected at 12–16 gestational weeks, whereas maternal urinary kisspeptin levels were determined using urine samples collected at 32–36 gestational weeks. Children’s urine samples were collected at age 6 and analyzed for urinary kisspeptin levels. Associations between ISOs exposure and urinary kisspeptin levels were evaluated using multiple linear regression and Bayesian Kernel Machine Regression (BKMR), and interaction with BPs was assessed via interaction terms and stratified analyses. Results Higher prenatal exposure to ISOs, including daidzein (DAD), glycitein (GLY) and equol (EQU) were associated with increased maternal urinary kisspeptin levels. In children, higher ISOs exposure was mainly associated with patterns toward lower kisspeptin levels among girls. GLY showed relatively high posterior inclusion probabilities in BKMR. Exploratory analyses suggested interactions between prenatal GLY and BPF exposures in relation to maternal and child urinary kisspeptin levels. Discussion Our study provides the first epidemiologic evidence that prenatal ISOs exposure, particularly GLY, may be associated with maternal urinary kisspeptin levels, whereas evidence for inverse associations with children’s urinary kisspeptin levels was mainly observed among girls. The exploratory interaction with BPF highlights the potential importance of considering exposures across pregnancy, although this exploratory finding warrants further corroboration.

Frontiers in EndocrinologyVol. 17
Fudan University (CN), Shanghai University of Medicine and Health Sciences (CN), Shanghai Institute of Pharmaceutical Industry (CN), Nanjing Medical University (CN)
Good health and well-being
Phytoestrogen effects and research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon